👉 In biotech, it is widely assumed that strong data naturally leads to strong execution . If experiments are rigorous and results are validated, progress should be inevitable. This belief is deeply embedded in scientific culture, and it feels rational. Yet in reality, biotech execution rarely breaks because of weak data . It breaks because teams avoid making hard choices. More precisely, they avoid explicitly acknowledging the tradeoffs that shape every execution path . 👉 F